Aethlon Medical, Inc.
AEMD
$0.45
$0.03769.12%
| Weiss Ratings | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.25 | |||
| Price History | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -13.08% | |||
| 30-Day Total Return | -28.68% | |||
| 60-Day Total Return | 18.73% | |||
| 90-Day Total Return | 18.45% | |||
| Year to Date Total Return | -43.75% | |||
| 1-Year Total Return | -73.92% | |||
| 2-Year Total Return | -88.46% | |||
| 3-Year Total Return | -96.48% | |||
| 5-Year Total Return | -97.74% | |||
| 52-Week High % Change | -77.71% | |||
| 52-Week Low % Change | 73.64% | |||
| Price | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.85 | |||
| 52-Week Low Price | $0.24 | |||
| 52-Week Low Price (Date) | Aug 05, 2024 | |||
| 52-Week High Price (Date) | Mar 25, 2024 | |||
| Valuation | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.96M | |||
| Enterprise Value | 1.86M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.60 | |||
| Earnings Per Share Growth | -68.20% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 1.33 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.45 | |||
| Enterprise Value/EBITDA (TTM) | -0.20 | |||
| Enterprise Value/EBIT | -0.19 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 13.96M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 619 941 0360 | |||
| Address | 11555 Sorrento Valley Road San Diego, CA 92121 | |||
| Website | www.aethlonmedical.com | |||
| Country | United States | |||
| Year Founded | 1984 | |||
| Profitability | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -72.47% | |||
| Return on Equity | -- | |||
| Income Statement | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -9.49M | |||
| EBIT (TTM) | -9.83M | |||
| Net Income (TTM) | -9.56M | |||
| Net Income Avl. to Common (TTM) | -9.56M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 49.37% | |||
| EPS Diluted (TTM) | -1.60 | |||
| EPS Diluted Growth (Q YOY) | 90.87% | |||
| Balance Sheet | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.83M | |||
| Cash Per Share (Q) | $0.35 | |||
| Total Current Assets (Q) | 4.97M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 4.33M | |||
| Current Ratio (Q) | 2.801 | |||
| Book Value Per Share (Q) | $0.31 | |||
| Total Assets (Q) | 6.53M | |||
| Total Current Liabilities (Q) | 1.77M | |||
| Total Debt (Q) | 724.80K | |||
| Total Liabilities (Q) | 2.19M | |||
| Total Common Equity (Q) | 4.33M | |||
| Cash Flow | AEMD - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -7.10K | |||
| Cash from Financing (TTM) | 5.41M | |||
| Net Change in Cash (TTM) | -3.15M | |||
| Levered Free Cash Flow (TTM) | -5.55M | |||
| Cash from Operations (TTM) | -8.54M | |||
